261 related articles for article (PubMed ID: 30995807)
1. Discovery of Nosiheptide, Griseoviridin, and Etamycin as Potent Anti-Mycobacterial Agents against Mycobacterium avium Complex.
Hosoda K; Koyama N; Kanamoto A; Tomoda H
Molecules; 2019 Apr; 24(8):. PubMed ID: 30995807
[No Abstract] [Full Text] [Related]
2. Development of an in vivo-mimic silkworm infection model with Mycobacterium avium complex.
Yagi A; Yamazaki H; Terahara T; Yang T; Hamamoto H; Imada C; Tomoda H; Uchida R
Drug Discov Ther; 2021 Jan; 14(6):287-295. PubMed ID: 33250497
[TBL] [Abstract][Full Text] [Related]
3. Difference in drug susceptibility distribution and clinical characteristics between
Wang W; Yang J; Wu X; Wan B; Wang H; Yu F; Guo Y
J Med Microbiol; 2021 May; 70(5):. PubMed ID: 33999797
[No Abstract] [Full Text] [Related]
4. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
Huang CC; Wu MF; Chen HC; Huang WC
J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex.
Brown-Elliott BA; Philley JV; Griffith DE; Thakkar F; Wallace RJ
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872065
[TBL] [Abstract][Full Text] [Related]
7. Comparing the Genotype and Drug Susceptibilities between Mycobacterium avium and Mycobacterium intracellulare in China.
Zheng HW; Pang Y; He GX; Song YY; Zhao YL
Biomed Environ Sci; 2017 Jul; 30(7):517-525. PubMed ID: 28756811
[TBL] [Abstract][Full Text] [Related]
8. Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan.
Yamaba Y; Ito Y; Suzuki K; Kikuchi T; Ogawa K; Fujiuchi S; Hasegawa N; Kurashima A; Higuchi T; Uchiya KI; Watanabe A; Niimi A
J Infect Chemother; 2019 Dec; 25(12):995-1000. PubMed ID: 31239192
[TBL] [Abstract][Full Text] [Related]
9. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility and molecular characterization of Mycobacterium intracellulare in China.
Zhao X; Wang Y; Pang Y
Infect Genet Evol; 2014 Oct; 27():332-8. PubMed ID: 25131955
[TBL] [Abstract][Full Text] [Related]
11. Nationwide analysis of Mycobacterium chimaera and Mycobacterium intracellulare isolates: Frequency, clinical importance, and molecular and phenotypic resistance profiles.
Truden S; Žolnir-Dovč M; Sodja E; Starčič Erjavec M
Infect Genet Evol; 2020 Aug; 82():104311. PubMed ID: 32247868
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium.
Deshpande D; Gumbo T
Future Microbiol; 2011 Apr; 6(4):433-9. PubMed ID: 21526944
[TBL] [Abstract][Full Text] [Related]
13. Mavintramycin A is a promising antibiotic for treating
Hosoda K; Koyama N; Shigeno S; Nishimura T; Hasegawa N; Kanamoto A; Ohshiro T; Tomoda H
Antimicrob Agents Chemother; 2024 Mar; 68(3):e0091723. PubMed ID: 38334410
[No Abstract] [Full Text] [Related]
14. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations.
Andréjak C; Almeida DV; Tyagi S; Converse PJ; Ammerman NC; Grosset JH
Antimicrob Agents Chemother; 2015 Apr; 59(4):2129-35. PubMed ID: 25624335
[TBL] [Abstract][Full Text] [Related]
16. Steffimycin E, a new anti-mycobacterial agent against Mycobacterium avium complex, produced by Streptomyces sp. OPMA02852.
Koyama N; Shigeno S; Kanamoto A; Tomoda H
J Antibiot (Tokyo); 2020 Aug; 73(8):581-584. PubMed ID: 32132675
[TBL] [Abstract][Full Text] [Related]
17. In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates.
Lin S; Hua W; Wang S; Zhang Y; Chen X; Liu H; Shao L; Chen J; Zhang W
BMC Microbiol; 2022 Jul; 22(1):175. PubMed ID: 35804298
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014.
Lee MR; Chien JY; Huang YT; Liao CH; Shu CC; Yu CJ; Hsueh PR
Int J Antimicrob Agents; 2017 Jul; 50(1):35-40. PubMed ID: 28478210
[TBL] [Abstract][Full Text] [Related]
19. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
Tomioka H; Sato K; Saito H
Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity and clinical efficacy of sparfloxacin in Mycobacterium avium-intracellulare complex infection.
Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Handa M; Munekata E
J Int Med Res; 2004; 32(5):530-9. PubMed ID: 15458286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]